… metastatic PD-L1 high non-small cell lung cancer (NSCLC). The GALAXIES Lung-201 …

… have stopped developing an experimental lung cancer drug, belrestotug, after it … dostarlimab for treating advanced non-small cell lung cancer (NSCLC), did not demonstrate sufficient … stage lung cancer trial. NSCLC is the most common type of lung cancer in …

… terminated development of their experimental lung cancer therapy after its failure to … ’s dostarlimab for treating non-small cell lung cancer, did not demonstrate sufficient efficacy … in the ongoing late-stage lung cancer trial. (Reporting by Kamal Choudhury …

… for all non-squamous non-small cell lung cancer (NSQ NSCLC) patients and is …

… against advanced non-small cell lung cancer (NSCLC), a … advanced non-small cell lung cancer lacking targetable driver … advanced non-small cell lung cancer without targetable … non-small cell lung cancer treatmentanlotinib efficacy in lung cancer therapycancer …

… non-squamous non-small cell lung cancer, according to a … for non-squamous non-small cell lung cancer,” Dr. David Spetzler … non-squamous non-small cell lung cancer through multiple diagnostic … non-squamous non-small cell lung cancer underscores this commitment …

… defined patient population of non-small cell lung cancer (NSCLC). The biomarker-focused Phase …

… a type of non–small cell lung cancer (NSCLC)—transforms into small cell lung cancer (SCLC), a distinct mutational … the management of EGFR‐mutated lung cancers that undergo transformation," the … and primary non-small cell lung cancers. Cancer Med. 2025;14 …

… -4224, in patients with non-small cell lung cancer (NSCLC). OX-4224 is an … of solid tumours, including non-small cell lung cancer (NSCLC).

… patients with extensive-stage small cell lung cancer (SCLC). SCLC grows and spreads at … than other types of lung cancer, and accounts for approximately … Novello, president Women Against Lung Cancer in Europe and head … cases of non-small lung cancer, as well as …